Literature DB >> 8434621

Familial Mediterranean fever in the colchicine era: the fate of one family.

D Zemer1, A Livneh, M Pras, E Sohar.   

Abstract

In order to demonstrate the effect of prophylactic colchicine treatment on the natural history of familial Mediterranean fever (FMF), a family is presented with 6 out of 9 siblings affected by FMF. Each patient represents a different stage of the amyloidotic kidney disease of FMF and the effect of continuous colchicine treatment on its course. Considered together, the members of this family present an almost complete clinical, genetic, and behavioral picture of the disease.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8434621     DOI: 10.1002/ajmg.1320450311

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  6 in total

Review 1.  Anti-amyloid drugs: potential in the treatment of diseases associated with aging.

Authors:  R Kisilevsky
Journal:  Drugs Aging       Date:  1996-02       Impact factor: 3.923

2.  Successful pregnancy in a familial Mediterranean fever patient following assisted reproduction.

Authors:  E C Ditkoff; M V Sauer
Journal:  J Assist Reprod Genet       Date:  1996-09       Impact factor: 3.412

3.  A survey of phenotype II in familial Mediterranean fever.

Authors:  M Melikoğlu; H Ozdoğan; C Korkmaz; O Kasapçopur; N Arisoy; S Akkuş; Z Fresko; H Yazici
Journal:  Ann Rheum Dis       Date:  2000-11       Impact factor: 19.103

4.  Safety of colchicine therapy during pregnancy.

Authors:  Ong Michael; Ran D Goldman; Gideon Koren
Journal:  Can Fam Physician       Date:  2003-08       Impact factor: 3.275

Review 5.  Monogenic autoinflammatory syndromes: state of the art on genetic, clinical, and therapeutic issues.

Authors:  Francesco Caso; Donato Rigante; Antonio Vitale; Orso Maria Lucherini; Luisa Costa; Mariangela Atteno; Adele Compagnone; Paolo Caso; Bruno Frediani; Mauro Galeazzi; Leonardo Punzi; Luca Cantarini
Journal:  Int J Rheumatol       Date:  2013-10-24

6.  Activated charcoal significantly reduces the amount of colchicine released from Gloriosa superba in simulated gastric and intestinal media.

Authors:  Shukry Zawahir; Indika Gawarammana; Paul I Dargan; Mahfoudh Abdulghni; Andrew H Dawson
Journal:  Clin Toxicol (Phila)       Date:  2017-05-23       Impact factor: 4.467

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.